Cargando…
Risk Assessment for Cardiovascular Disease Using the Framingham Risk Score and Globorisk Score Among Newly Diagnosed Metabolic Syndrome Patients
PURPOSE: The presence of metabolic syndrome (MetS) is linked to an increased risk of cardiovascular disease (CVD) development. In this study, CVD risk was calculated among individuals with newly diagnosed MetS using the Framingham Risk Score (FRS) and Globorisk Score. The FRS and Globorisk score are...
Autores principales: | Adil, Syed Omair, Uddin, Fareed, Musa, Kamarul Imran, Khan, Asima, Shakeel, Areebah, Shafique, Kashif, Islam, Md Asiful |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10518264/ https://www.ncbi.nlm.nih.gov/pubmed/37753441 http://dx.doi.org/10.2147/IJGM.S423151 |
Ejemplares similares
-
Role of anthropometric indices as a screening tool for predicting metabolic syndrome among apparently healthy individuals of Karachi, Pakistan
por: Adil, Syed Omair, et al.
Publicado: (2023) -
Prevalence of Metabolic Syndrome among Apparently Healthy Adult Population in Pakistan: A Systematic Review and Meta-Analysis
por: Adil, Syed Omair, et al.
Publicado: (2023) -
The Ten-Year Risk Prediction for Cardiovascular Disease for Malaysian Adults Using the Laboratory-Based and Office-Based (Globorisk) Prediction Model
por: Che Nawi, Che Muhammad Nur Hidayat, et al.
Publicado: (2022) -
Performance of the SCORE and Globorisk cardiovascular risk prediction models: a prospective cohort study in Dutch general practice
por: Schoofs, Merle CA, et al.
Publicado: (2022) -
A comparative assessment between Globorisk and WHO cardiovascular disease risk scores: a population-based study
por: Dehghan, Azizallah, et al.
Publicado: (2023)